A SNP in Steroid Receptor Coactivator-1 Disrupts a GSK3β Phosphorylation Site and Is Associated with Altered Tamoxifen Response in Bone
Ryan J. Hartmaier(AstraZeneca (United States)), Steffi Oesterreich(University of Pittsburgh), Todd C. Skaar(Indiana University School of Medicine), Ryan Gillihan(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Jianming Xu(Baylor College of Medicine), Anne Nguyen(Indiana University School of Medicine), Jill A. Hayden(Northwestern University), James M. Rae(University of Michigan), Vered Stearns(Johns Hopkins University), Bert W. O’Malley(Baylor College of Medicine), N. Lynn Henry(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Powel H. Brown(The University of Texas MD Anderson Cancer Center), A. V. Lee(Baylor College of Medicine), Santosh Philips(Indiana University School of Medicine), Andreas S. Richter(Baylor College of Medicine), J. Z. Sallit(Baylor College of Medicine), Jun Wang(South China Agricultural University), Lü Li(McGill University), Sean E. McGuire(The University of Texas MD Anderson Cancer Center), David A. Flockhart(Indiana University – Purdue University Indianapolis), Faouzi Azzouz(Indiana University Health)
Cited by 20
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Graphene and graphene oxide: biofunctionalization and applications in biotechnology
|Trends in biotechnology|2011|1.5k